c Treponema pallidum PCR (Tp-PCR) testing now is recommended as a valid tool for the diagnosis of primary or secondary syphilis. The objectives were to systematically review and determine the optimal specific target gene to be used for Tp-PCR. Comparisons of the performance of the two main targets are tpp47 and polA genes were done using meta-analysis. Three electronic bibliographic databases, representing abstract books from five conferences specialized in infectious diseases from January 1990 to March 2015, were searched. Search keywords included ("syphilis" OR "Treponema pallidum" OR "neurosyphilis") AND ("PCR" OR "PCR" OR "molecular amplification"). We included diagnostic studies assessing the performance of Tp-PCR targeting tpp47 (tpp47-Tp-PCR) or the polA gene (polA-Tp-PCR) in ulcers from early syphilis. All studies were assessed against quality criteria using the QUADAS-2 tool. Of 37 studies identified, 62.2% were judged at low risk of bias or applicability. Most used the U.S. Centers for Disease Control and Prevention (CDC) case definitions for primary or secondary (early) syphilis (89.2%; n ‫؍‬ 33); 15 (40.5%) used darkfield microscopy (DFM). We did not find differences in sensitivity and specificity between the two Tp-PCR methods in the subgroup of studies using adequate reference tests. Among studies using DFM as the reference test, sensitivities were 79.8% (95% confidence intervals [CI], 72.7 to 85.4%) and 71.4% (46.0 to 88.0%) for tpp47-Tp-PCR and polA-Tp-PCR (P ‫؍‬ 0.217), respectively; respective specificities were 95.3% (93.5 to 96.6%) and 93.7% (91.8 to 95.2%) (P ‫؍‬ 0.304). Our findings suggest that the two Tp-PCR methods have similar accuracy and could be used interchangeably.
S
ince January 2014, the U.S. Centers for Disease Control and Prevention (CDC) has proposed a new case definition to confirm the diagnosis of primary and secondary syphilis that includes Treponema pallidum amplification by PCR (Tp-PCR) (1) . In contrast, Tp-PCR was already included in the 2008 edition of the European guidelines (2) , which was recently updated (3) . In a previous meta-analysis, we demonstrated that Tp-PCR performed better in clinical specimens from ulcers or skin lesions than in blood or cerebrospinal fluid, but we also concluded that Tp-PCR accuracy was greatly influenced by the reference tests used for the diagnosis of syphilis (4) . In addition, there is no clear guidance as to which gene should be targeted by Tp-PCR, i.e., the 47-kDa lipoprotein membrane from T. pallidum (tpp47) or the polymerase A gene (polA). Recently, we compared the diagnostic performance and clinical usefulness of the two Tp-PCR methods in 272 oral or genital swabs from ulcers suggestive of syphilis, and we were able to show an almost perfect agreement (5) .
To compare the sensitivity and specificity of the two Tp-PCR methods on a larger sample size than that in a single study, we completed our first systematic review on this topic (4) and extended the search to all new studies published from January 2012 to March 2015 using Tp-PCR targeting the tpp47 or polA gene in ulcers from patients with early syphilis. We also performed a meta-analysis providing pooled estimates of the sensitivity, specificity, and likelihood ratios of Tp-PCR among studies using an adequate reference test, and we compared the performance of Tp-PCR between the two methods.
MATERIALS AND METHODS
Study design, search strategy, and selection criteria. We used the studies selected in a previous systematic review and meta-analysis (4) dedicated to assessing the diagnostic performance of Tp-PCR by syphilis stage and biological specimen used. The current study objectives were included in the first version of the protocol, which was modified consequently (available upon request). We completed the systematic review using the same procedure with data from January 2012 to March 2015. We restricted the selection to all human studies assessing the diagnostic performance of Tp-PCR targeting tpp47 (tpp47-Tp-PCR) or polA (polA-Tp-PCR) genes in ulcer swabs only and compared Tp-PCR to darkfield microscopy (DFM) or various combinations of serological assays by following the CDC case definitions (1).
Assessment of methodological quality. We followed the recent recommendations from the Cochrane review on diagnostic test accuracy (6) . The risk of bias and applicability were assessed using the modified form of the Quality Assessment for Diagnostic Accuracy Studies (QUADAS) tool (7) . In a stacked bar chart, we represented the percentage of included studies rated as low, high, or unclear risks for each of the four domains related to bias (index test and reference test) or applicability (patient selection and flow and timing). A study was judged a low risk of bias or low concern regarding applicability if all domains were rated as low. If one or more domains were judged high or unclear, then the study was considered at risk of bias or as having concerns regarding applicability (7) .
Data extraction. Three reviewers (A.G.A., S.L., and B.N.) screened abstracts of potentially relevant studies and applied the selection criteria. Reasons for exclusion were discussed, and discrepancies were solved by consensus. Data extraction was performed by two independent reviewers (A.G.A. and S.L.), and two-by-two tables were summarized for each selected study. Data were verified for consistency and accuracy. We collected the following data: author, journal, year of publication, place of study (country), syphilis stage (primary, secondary, or early syphilis), type of Tp-PCR (multiplex, standard, real time, or nested Tp-PCR), targeted gene (tpp47 or polA), reference tests used for the diagnosis of syphilis (DFM and/or serological assays), number of Tp-PCR positives among cases, and number of Tp-PCR negatives among controls (if available). Some studies provided separate data on different syphilis stages (primary, secondary, or early), leading to a larger number of groups than the number of studies selected. The corresponding author was contacted by email in the case of missing data or lack of precision.
Case definitions. We used the case definitions reported by the authors in their papers and further distinguished confirmed and probable syphilis cases by following the new CDC case definitions (1) . If the diagnosis of syphilis did not rely on the CDC case definitions or if the information was unknown, we considered the study as using inadequate or unknown reference tests. Studies following the CDC recommendations were placed in the adequate reference test group with a further subdivision between studies using DFM or other direct detection methods and those using serological assays.
Statistical analysis. We used the chi-square test to assess if the type of Tp-PCR used in studies was associated with the year of publication (Յ1999 versus Ն2000) and the geographical area of recruitment. We also tested if the proportion of studies using tpp47-Tp-PCR was different between those using an adequate (with DFM or serology) versus an inadequate or unknown reference test. For the assessment of the methodological quality of the selected studies, we presented the proportion of low, high, or unclear risk of bias for each of the 4 QUADAS-2 domains with their exact 95% confidence intervals by using the Clopper-Pearson method (8) .
We restricted the meta-analysis to studies using adequate reference tests only and distinguished between those using DFM and those using serology. We used the Rutter and Gatsonis hierarchical summary receiver operating characteristic (ROC) curve model (9) and the bivariate model (10) by following the recommendations from the Cochrane Collaboration (6) . A continuity correction of 0.5 was added to the whole analyzed data set if only one cell in one study is zero. We reported sensitivity, specificity, and positive and negative likelihood ratios obtained from bivariate models with 95% confidence intervals. Heterogeneity was measured in each subgroup with the indicator I 2 , which reflects the part of variance between studies that is due to factors other than chance (11) . If the heterogeneity was important (I 2 above 50%), then we explored predefined potential heterogeneity factors: the targeted gene (tpp47 versus polA) considered the primary predictor, the reference test group used (adequate reference tests based on DFM versus adequate reference tests based on serology), and the type of Tp-PCR (multiplex PCR versus other PCR methods).
We assessed the presence of publication bias among studies using adequate reference tests by performing a regression of diagnostic log odds ratio against 1/sqrt (effective sample size) weighted by effective sample size (Deeks' test) (12) ; P Ͻ 0.10 for the slope coefficient indicates significant asymmetry.
Analyses were performed using Stata IC 13 (StataCorp., College Station, TX) with the Stat packages midas and metandi to assess the existence of publication bias and R software, version 3.1.3 (R Foundation for Statistical Computing, Vienna, Austria; www.R-project.org), with the packages mada, meta, and mvmeta for the meta-analysis (13) . Statistical significance is defined as P Ͻ 0.05 (two-sided) except for the test on publication bias (P Ͻ 0.10).
RESULTS
Thirty-seven studies were retrieved by the systematic review, and 31 studies provided data on both sensitivity and specificity ( Table  1 ). The study flowchart is presented in Fig. 1 . Among studies providing data on both sensitivity and specificity (n ϭ 31), four used inadequate or unknown reference tests (12.9%) and were excluded from the meta-analysis. One experimental study (14) compared the two Tp-PCR methods on the basis of the same clinical specimens, but it did not provide any results of the reference tests. As we were unable to estimate the sensitivity and specificity for the Tp-PCR tests, this study was not included in the meta-analysis.
Most studies were conducted or published in the 2000s (75.7%; n ϭ 28) in journals with a focus on infectious diseases (51.4%; n ϭ 19) or sexually transmitted infections (32.4%; n ϭ 12). Studies were conducted in Africa (29.7%; n ϭ 11), Europe (27.0%; n ϭ 10), the Americas (24.3%; n ϭ 9), Asia (13.5%; n ϭ 5), and Australia (5.4%; n ϭ 2). The diagnosis of syphilis relied on DFM in 15 studies (40.5%). The tpp47 gene (78.4%; n ϭ 29) was used more frequently than polA (18.9%, n ϭ 7); one study assessed the two Tp-PCR methods using the same specimens (5). Multiplex Tp-PCR targeting Haemophilus ducreyi, T. pallidum, and herpes simplex virus was the more frequently used type of Tp-PCR (56.8%; n ϭ 21), followed by standard (21.6%; n ϭ 8), real-time (16.2%; n ϭ 6), and nested Tp-PCR (5.4%; n ϭ 2). In the studies published before 2000 (n ϭ 9), all used multiplex Tp-PCR, whereas 42.9% used it after 2000 (n ϭ 12Ͻ; P ϭ 0.003). Multiplex Tp-PCR was used less frequently in studies from European countries or Australia than in studies conducted in African, American, or Asian countries (8.3% versus 72.0%; P Ͻ 0.001).
Quality assessment of the selected studies. Among the 37 selected studies, 23 had an overall judgement of low risk of bias or low concern regarding applicability (62.2%) (see Appendix S1a in the supplemental material). The risk of bias was suspected mainly in five studies (13.5%), which used either an inadequate reference standard or, if used, the reference standard results were interpreted with prior knowledge of the results of the Tp-PCR. After exclusion of these five studies (see Appendix S1b), two studies remained at risk of bias or applicability due to the procedure used to select patients (6.1%). Four did not sufficiently detail how they performed Tp-PCR and were considered to have concerns regarding applicability (12.2%). Four studies did not provide sufficient data to judge if the patient flow introduced some bias into the results (12.2%). Finally, five studies with data on both sensitivity and specificity were considered as being potentially biased in at least one domain.
Pooled estimates of sensitivity, specificity, and likelihood ratios. Overall pooled sensitivity was not statistically different between studies using inadequate or unknown reference tests compared to those using adequate reference tests (52 respectively; P ϭ 0.358). We restricted the meta-analysis to studies using adequate reference tests and which provided data on both sensitivity and specificity (n ϭ 31) (Table 2 ). Globally, heterogeneity was large for pooled estimates of both sensitivity and specificity. The clinical value of Tp-PCR was good to rule in the diagnosis of syphilis with an overall positive likelihood ratio above 10. The negative likelihood ratio was below the cutoff of 0.10 proposed to rule out the diagnosis of syphilis.
When we compared the diagnostic performance of Tp-PCR to the type of reference test used, the pooled estimate for sensitivity was significantly higher in studies using DFM than in those using serological assays (P Ͻ 0.001), but heterogeneity remained high (Table 2 ). There was no statistical difference between the pooled estimates for specificity by type of reference tests used (P ϭ 0.803). In a sensitivity analysis, we excluded the five studies providing data for both sensitivity and specificity with a risk of bias, and findings were unchanged: sensitivity was 67.0% (95% CI, 57.4 to 75.3) and specificity was 95.2% (95% CI, 93.0 to 96.7). The positive likelihood ratio was 13.8 (95% CI, 8.9 to 21.3), and the negative likelihood ratio was 0.35 (95% CI, 0.26 to 0.45).
Comparison of the diagnostic performance of Tp-PCR by targeted gene (tpp47 versus polA). Overall pooled estimates for sensitivity or specificity were not significantly different between the two genes targeted (Table 2) , and heterogeneity remained high in the subgroups. Given that the type of reference tests used explained part of the heterogeneity in sensitivity, we stratified data on this factor. In the subgroup of studies using adequate reference tests based on DFM, the difference in sensitivity and specificity between tpp47-Tp-PCR and polA-Tp-PCR was not statistically significant (Table 2 ). In the subgroup of studies using adequate reference tests based on serology, one study provided data on polA-Tp-PCR, and P values comparing pooled estimates for sensitivity and specificity are not reported.
Summary ROC curves for tpp47-Tp-PCR and polA-Tp-PCR among studies using adequate reference tests are presented in Fig.  2A and B, respectively, with a larger confidence region for polATp-PCR due to the small number of studies. Publication bias. Among the 31 selected studies using adequate reference tests, the diagnostic odds ratio varied according to the sample size, and the P value was below the prespecified cutoff fixed at 0.10 (P ϭ 0.075), suggesting that the funnel plot was asymmetric and publication bias was likely. For studies having a 1/sqrt(effective sample size) above 0.14 (small studies), the diagnostic odds ratios were higher, suggesting that smaller studies selected tended to have higher diagnostic odds ratios than larger studies (see Appendix S2 in the supplemental material). We further recalculated the sensitivity, specificity, and positive and negative likelihood ratios among studies having a 1/sqrt(effective sample size) lower than 0.14: these were 61.5% (95% CI, 51.1 to 70.8), 95.5% (95% CI, 93.6 to 96.9), 13.7 (range, 8.8 to 20.9), and 0.40 (range, 0.30 to 0.52), respectively. The results did not modify our conclusion regarding the accuracy and clinical utility of Tp-PCR.
DISCUSSION
This meta-analysis suggests that there is no difference between the diagnostic accuracy of the two Tp-PCR methods used in ulcers from early syphilis. When we used DFM as a reference test, the accuracy and clinical value of the two Tp-PCR methods were similar. In the case of a positive tpp47-Tp-PCR or polA-Tp-PCR, the likelihood ratio of syphilis was very high, i.e., above the recommended cutoff of 10 (52). However, in the case of negative results, the two Tp-PCRs were less useful to rule out syphilis, since negative likelihood ratios were above the recommended cutoff of 0.1 (52) . Finally, we confirmed our previous findings showing that the diagnostic performance of Tp-PCR was influenced by the reference test used, with a significantly higher sensitivity when DFM was used than when serology was the reference (4, 51) .
In a recent study, we compared the performance of tpp47-Tp-PCR to that of polA-Tp-PCR on the same clinical specimens and found an almost perfect agreement between the two targets (5). In 2001, Liu et al. also compared the results of tpp47-Tp-PCR and polA-Tp-PCR in a subgroup analysis of an experimental study using 112 genitourinary specimens of unknown origin with the aim to validate the diagnostic method used (14) . The authors concluded that the two Tp-PCRs were highly concordant. Finally, The added value of the current study is the presentation of pooled estimates of the accuracy of the two Tp-PCR methods using data from various sources of information and allowing the comparisons of the diagnostic parameters on a larger sample size than that in a single study. Nevertheless, our study presents some limitations related to the impossibility of controlling and standardizing the reference tests used in the different studies. Consequently, we could not exclude interstudy variability in the definition of the reference groups (cases and controls). However, we do not consider that this had an impact on the results of comparing the performance of the two Tp-PCR methods. Moreover, the absence of differences regarding the sensitivities and specificities of tpp47-Tp-PCR and polA-Tp-PCR is concordant with the almost perfect agreement found in our recent study (5) . In the same way, we could not strictly control for the procedure regarding Tp-PCR. We were not able to assess if the limit of detection for judging Tp-PCR as positive could explain some part of the heterogeneity in the results. We also showed in a sensitivity analysis that after the exclusion of studies with a risk of bias, the results were unchanged. A publication bias was suspected among selected studies, with better sensitivities in studies having small effective sample sizes than in larger studies. This explains the greater asymmetry of the funnel plot in studies having smaller sample sizes and larger diagnostic odds ratios due to the maximization of their sensitivities. In order to make the funnel plot symmetric, small studies with low sensitivities are lacking. Nonetheless, the exclusion of small studies did not modify the interpretation of the findings.
Our results confirm the clinical utility of Tp-PCR in the diagnosis of orogenital ulcerative diseases suggestive of syphilis, with DFM as a reference. In addition, even after several decades of Tp-PCR use in practice, it is always pertinent to assess the relevance of the targets used and to demonstrate a posteriori that the two Tp-PCR methods have a similar diagnostic performance. Thanks to the use of pooled data, we were sufficiently powered to reach precise estimations of Tp-PCR accuracy, especially as it relates to specificity. The heterogeneity in the results between studies was taken into account by the use of a random effects model, but some unexplained heterogeneity remained after stratification on the type of reference test (adequate versus direct detection methods) or on the targeted gene.
In the future, one way to formally conclude that the two TpPCRs are similarly useful for medical decision-making would be to conduct a comparative study where the attribution of the type of Tp-PCR would be randomized with the same reference test used in the two arms. If the differences in sensitivity and specificity and their 95% CI lie in a prespecified equivalence margin, the equivalence could be claimed. In addition, the study could be completed by a benefit study to assess if the similarity in the accuracy of the two Tp-PCRs also was associated with no difference in the clinical benefit for the patients in terms of treatment response or evolution to more advanced stages using a predefined equivalence margin. In conclusion, these results complement our previous findings (5) and suggest that the two targets can be used interchangeably in clinical practice.
